Literature DB >> 29354873

Clinical characteristics associated with subcutaneous tophi formation in Chinese gout patients: a retrospective study.

Lidan Ma1,2, Ruixia Sun1, Zhaotong Jia1, Yaowu Zou3, Ying Xin1, Xiaoyu Cheng1, Tian Liu1, Lingling Cui3, Zhen Liu3, Xinjiang Wu4, Changgui Li5,6.   

Abstract

The objective of this study is to analyze clinical characteristics associated with the formation of subcutaneous tophi among Chinese gout patients. It was a retrospective outpatient cohort study. Five thousand six hundred ninety-three gout patients treated at the Affiliated Hospital of Qingdao University from March 2011 to February 2016 were included and divided into the tophus group and non-tophus group according to the presence of megascopic tophus. Relevant clinical information and biochemical parameters were analyzed to identify potential risk factors for the incidence of subcutaneous tophi. There are significant difference (P < 0.05) between the tophus and non-tophus groups in gender, family history, exercise, incidence of obesity, hypertension, renal dysfunction, kidney stone, coronary heart disease, and upper limb joint involvement. Between the two groups, significant difference (P < 0.01) was detected in the onset age (43.80 ± 13.82 years vs. 45.40 ± 13.77 years), duration of disease (10.28 ± 7.54 years vs. 5.11 ± 6.06 years), number of joint involved (3.11 ± 2.15 vs. 1.81 ± 1.35), systolic pressure (138.53 ± 19.46 mmHg vs. 133.87 ± 17.93 mmHg), diastolic pressure (89.55 ± 12.73 mmHg vs. 87.48 ± 11.77 mmHg), serum uric acid (487.15 ± 120.13 μmol/L vs. 458.89 ± 119.04 μmol/L), creatinine (93.87 ± 54.19 μmol/L vs. 85.51 ± 37.71 μmol/L), and creatinine clearance rate (Ccr) (93.05 ± 48.7 mL/min vs. 106.61 ± 51.76 mL/min). Logistic regression analysis suggests that duration of disease, number of joints involved, involvement of upper limb joints, kidney stones, diastolic pressure, and serum uric acid are associated with the subcutaneous tophi formation, while exercise and obesity are protective factors. The present study has identified several clinical parameters (such as duration of disease, involvement of upper limb joints, involved joints, kidney stone, hypertension) as risk factors for the incidence of subcutaneous tophi, which provides insights into the treatment and prevention of tophus.

Entities:  

Keywords:  China; Gout; Risk factor; Tophus

Mesh:

Substances:

Year:  2018        PMID: 29354873     DOI: 10.1007/s10067-017-3969-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  27 in total

1.  Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls.

Authors:  Giuseppe Lippi; Giorgio Brocco; Massimo Franchini; Federico Schena; Giancesare Guidi
Journal:  Clin Chem Lab Med       Date:  2004       Impact factor: 3.694

2.  The guidelines for prevention and control of overweight and obesity in Chinese adults.

Authors:  Chunming Chen; Frank C Lu
Journal:  Biomed Environ Sci       Date:  2004       Impact factor: 3.118

3.  2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Authors:  Dinesh Khanna; John D Fitzgerald; Puja P Khanna; Sangmee Bae; Manjit K Singh; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

4.  Independent impact of gout on the risk of diabetes mellitus among women and men: a population-based, BMI-matched cohort study.

Authors:  Young Hee Rho; Na Lu; Christine E Peloquin; Ada Man; Yanyan Zhu; Yuqing Zhang; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2014-10-02       Impact factor: 19.103

5.  Diagnostic criteria for diabetes mellitus and other categories of glucose intolerance: 1997 criteria by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (ADA), 1998 WHO consultation criteria, and 1985 WHO criteria. World Health Organization.

Authors:  G Puavilai; S Chanprasertyotin; A Sriphrapradaeng
Journal:  Diabetes Res Clin Pract       Date:  1999-04       Impact factor: 5.602

6.  Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene.

Authors:  S-J Chang; C-J Chen; F-C Tsai; H-M Lai; P-C Tsai; M-H Tsai; Y-C Ko
Journal:  Rheumatology (Oxford)       Date:  2008-03-19       Impact factor: 7.580

7.  Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey.

Authors:  Puja P Khanna; George Nuki; Thomas Bardin; Anne-Kathrin Tausche; Anna Forsythe; Amir Goren; Jeffrey Vietri; Dinesh Khanna
Journal:  Health Qual Life Outcomes       Date:  2012-09-22       Impact factor: 3.186

8.  Visceral fat obesity is highly associated with primary gout in a metabolically obese but normal weighted population: a case control study.

Authors:  Jennifer Lee; Ji-Yeon Lee; Jae-Ho Lee; Seung-Min Jung; Young Sun Suh; Jung-Hee Koh; Seung-Ki Kwok; Ji Hyeon Ju; Kyung-Su Park; Sung-Hwan Park
Journal:  Arthritis Res Ther       Date:  2015-03-24       Impact factor: 5.156

9.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Tuhina Neogi; Tim L Th A Jansen; Nicola Dalbeth; Jaap Fransen; H Ralph Schumacher; Dianne Berendsen; Melanie Brown; Hyon Choi; N Lawrence Edwards; Hein J E M Janssens; Frédéric Lioté; Raymond P Naden; George Nuki; Alexis Ogdie; Fernando Perez-Ruiz; Kenneth Saag; Jasvinder A Singh; John S Sundy; Anne-Kathrin Tausche; Janitzia Vaquez-Mellado; Steven A Yarows; William J Taylor
Journal:  Ann Rheum Dis       Date:  2015-10       Impact factor: 19.103

10.  Hypertension and the risk of incident gout in a population-based study: the atherosclerosis risk in communities cohort.

Authors:  Mara A McAdams-DeMarco; Janet W Maynard; Alan N Baer; Josef Coresh
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-06-13       Impact factor: 3.738

View more
  7 in total

1.  Seasonal variation in the internet searches for gout: an ecological study.

Authors:  Sinan Kardeş
Journal:  Clin Rheumatol       Date:  2018-10-29       Impact factor: 2.980

2.  Simple metabolic markers associated with tophaceous gout.

Authors:  Wei Liu; Hui Song; Siliang Man; Hongchao Li; Siming Gao
Journal:  Clin Rheumatol       Date:  2021-07-15       Impact factor: 2.980

3.  Risk factors of ultrasound-detected tophi in patients with gout.

Authors:  Beilei Lu; Qing Lu; Beijian Huang; Cuixian Li; Fengyang Zheng; Peilei Wang
Journal:  Clin Rheumatol       Date:  2020-02-15       Impact factor: 2.980

4.  Methodological quality of cohort study on rheumatic diseases in China: A systematic review.

Authors:  Huan Zhang; Guoxiang Yi; Mingzhu Dai; Yanping Li; Bin Wu
Journal:  PLoS One       Date:  2020-04-23       Impact factor: 3.240

5.  Presence of tophi is associated with a rapid decline in the renal function in patients with gout.

Authors:  Yoon-Jeong Oh; Ki Won Moon
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

Review 6.  Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.

Authors:  James M Gwinnutt; Maud Wieczorek; Giulio Cavalli; Andra Balanescu; Heike A Bischoff-Ferrari; Annelies Boonen; Savia de Souza; Annette de Thurah; Thomas E Dorner; Rikke Helene Moe; Polina Putrik; Javier Rodríguez-Carrio; Lucía Silva-Fernández; Tanja Stamm; Karen Walker-Bone; Joep Welling; Mirjana I Zlatković-Švenda; Francis Guillemin; Suzanne M M Verstappen
Journal:  RMD Open       Date:  2022-03

7.  Effects of fenofibrate therapy on renal function in primary gout patients.

Authors:  Xinde Li; Wenyan Sun; Jie Lu; Yuwei He; Ying Chen; Wei Ren; Lingling Cui; Zhen Liu; Can Wang; Xuefeng Wang; Lidan Ma; Xiaoyu Cheng; Lin Han; Hailong Li; Hui Zhang; Xuan Yuan; Xiaopeng Ji; Aichang Ji; Tony R Merriman; Changgui Li
Journal:  Rheumatology (Oxford)       Date:  2021-11-03       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.